The poster will be made available on the Presentations & Research page of Unicycive’s website following the poster ...

MediBeacon’s CEO, Steven Hanley, will present at the upcoming Stifel Healthcare Conference in New York on Tuesday, Nov. 11, 2025 at 5:40 AM PST / 8:40 AM EST. Media and Investor Contact Carrie ...

Reverting to pre-COVID telehealth policies could reduce access to care for kidney transplant recipients who live in ...

Kidney transplant recipients with active or high risk for antibody-mediated rejection reported transplant benefits but still experienced physical restrictions and psychological concerns, according to ...

Allosite Therapeutics, a biotechnology company discovering and developing innovative integrin therapies for kidney diseases and other immunologic conditions, today announced that the company will ...

The Key Advances in Nephrology collection offers a unique series of specially commissioned ‘Year in Review’ articles that highlight the key discoveries made each year. In these articles, leading ...

Unicycive Therapeutics (UNCY) announced that it will present new oxylanthanum carbonate, OLC, data at the American Society of Nephrology, ASN, ...

Late-breaking Phase 2 trial data evaluating the safety and efficacy of 25 mg of lorundrostat in participants with hypertension and comorbid CKD to be presented~~ Phase 3 data of the Launch-HTN Trial ...

myCME is the premier destination for continuing medical education (CME) and continuing education (CE), committed to providing high-quality, evidence-based, and user-friendly courses tailored to the ...

Renalys Pharma, Inc. (Headquarters: Chuo-ku, Tokyo; "Renalys") is pleased to announce the company is providing financial support for the Alport Syndrome Registry Study organized by the Japanese ...

The Division of Pediatric Nephrology of the Department of Pediatrics, Baylor College of Medicine, is dedicated to training fellows to become leaders in pediatric nephrology. One of the largest ...